Lonza
Trending Articles
Related Content
Finance
Lonza divests Capsules & Health Ingredients business to Lone Star Funds for $3bn
Lonza has agreed to sell its Capsules & Health Ingredients division to private equity firm Lone Star Funds while retaining a 40% stake, marking what the company describes as the final step in its transformation into a pure-play CDMO
Ingredients
Protect oxygen-sensitive ingredients with Capsugel Plantcaps capsules
At Lonza Capsules & Health Ingredients (CHI), we know how challenging it can be to formulate supplements with oxygen-sensitive ingredients. From efficacy to shelf-life concerns, these ingredients can be tricky—making capsule selection a critical decision
Ingredients
Capsugel Plantcaps: Consumer appeal meets uncompromising performance
You know that the modern healthy lifestyle consumer is savvy, well-informed and increasingly discerning. They're not just looking for a standard vegan capsule product—they want products made with “real” ingredients, free from artificial chemicals, pesticides and preservatives
Ingredients
The innovator’s toolkit: Turning formulation challenges into market successes
A bold idea can take your next product a long way, but sometimes, formulation and technical barriers can slow your journey to success. From tackling ingredient incompatibility, to masking unpleasant scents and protecting sensitive ingredients, there are a range of formulation complexities to consider when creating nutraceuticals that not only perform but truly resonate with consumers.